ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

QTRX Quanterix Corporation

23.56
0.63 (2.75%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 414,961
Bid Price 23.19
Ask Price 23.94
News -
Day High 23.94

Low
10.02

52 Week Range

High
29.70

Day Low 22.64
Company Name Stock Ticker Symbol Market Type
Quanterix Corporation QTRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.63 2.75% 23.56 20:00:00
Open Price Low Price High Price Close Price Prev Close
22.93 22.64 23.94 23.56 22.93
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,549 414,961 $ 23.54 $ 9,767,533 - 10.02 - 29.70
Last Trade Time Type Quantity Stock Price Currency
18:21:26 5 $ 23.30 USD

Quanterix Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
897.92M 38.06M - 122.37M -32.33M -0.85 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Quanterix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QTRX Message Board. Create One! See More Posts on QTRX Message Board See More Message Board Posts

Historical QTRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week25.5926.1821.5322.83488,117-2.03-7.93%
1 Month23.8729.7021.5325.57384,870-0.31-1.30%
3 Months25.8529.7021.5324.70337,162-2.29-8.86%
6 Months27.4329.7019.3524.14354,358-3.87-14.11%
1 Year10.3729.7010.0222.71355,66313.19127.19%
3 Years51.6069.226.3125.05375,279-28.04-54.34%
5 Years24.2992.576.3129.04311,999-0.73-3.01%

Quanterix Description

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability.

Your Recent History

Delayed Upgrade Clock